ArticleCancer immunology, immunotherapy : CII2014

Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.

Britnie R James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.